Advertisement
Advertisement

BYSI

BYSI logo

BeyondSpring Inc

1.54
USD
-0.09
-5.52%
Dec 18, 15:59 UTC -5
Closed
...

BeyondSpring Inc Profile

About

BeyondSpring Inc. is a clinical stage biopharmaceutical company. It focused on the development of cancer therapies. The Company's lead product consists of into a Phase 3 clinical trial as a direct anticancer agent in non-small cell lung cancer and a Phase 2/3 clinical trial in the prevention of chemotherapy-induced Neutropenia. BeyondSpring Inc. is based in New York, United States.

Info & Links

CEO

Lan Huang

Headquarters

28 LIBERTY STREET,39TH FLOOR
NEW YORK, NY 10005, UNITED STATES

Auditor

Ernst & Young Hua Ming LLP

Share holders

56

Employees

103

BeyondSpring Inc Statistics

Valuation Measures

Market Capitalization2

60.11M

Enterprise Value

51.71M

Enterprise Value/EBITDA(ttm)

-1.12

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

--

Price to Book(mrq)

--

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

75.00%

Operating Margin(ttm)

--

Profit Margin(ttm)

-3322.89%

Return on Equity(ttm)

--

Return on Invested Capital(ttm)

-135.42%

Return on Assets(ttm)

--

Income Statement

Revenue(ttm)

1.01M

Revenue Per Share(ttm)

--

Gross Profit(ttm)

1.01M

EBITDA(ttm)3

-46.22M

Net Income Available to Common(ttm)

-44.87M

Diluted EPS(ttm)

--

Share Statistics

Beta (5Y Monthly)

0.25

52-Week Change

73.25%

S&P 500 52-Week Change

23.87%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

--

Dividend Yield

0.00%

Float4

27.59M

% Held by Insiders

29.31%

% Held by Institutions

40.29%

Balance Sheet

Total Cash(mrq)

14.36M

Total Cash Per Share(mrq)

--

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

--

Quick Ratio(mrq)

--

Book Value Per Share(mrq)

--

Cash Flow

Operating Cash Flow Per Share(ytd)

--

Free Cash Flow(ytd)

0.00

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement